AB SCIEX expands presence in India

AB SCIEX has announced that it has acquired the mass spectrometry business of Labindia Instruments Pvt. Ltd. The acquisition marks AB SCIEX’s increasing investment in India, combining their global resources with well established local expertise. They have been actively involved in applying the potential of mass spectrometry to assist in protecting the health and safety of India’s population.

The transition of Labindia’s mass spectrometry business, including customer relationships, personnel and application support facilities, to AB SCIEX is due to the successful partnership they have nurtured over the past 15 years. The expansion of its commercial operations in India will create new opportunities for customer interactions, collaborations and innovation.

Umesh Pawa, Managing Director, AB SCIEX India, said, “Expansion of AB SCIEX’s commercial operations in India will strengthen our position and help us build on the success of Labindia’s mass spectrometry business as well as execute on our growth strategy. By integrating Indian sales, service and support functions into AB SCIEX's global resources and operational excellence, we will simplify the process for customers to do business with AB SCIEX and drive the highest standard of support, further enhancing customer satisfaction levels. We will now be able to engage in a new level of dialogue with Indian scientists, who are among the leaders pushing the limits to improve life in this region.”

AB SCIEX and Labindia are working very closely to ensure that the transition goes as smoothly as possible.

For more information please visit ref="http://www.absciex.com/india">www.absciex.com/india